Report Highlights
The global market for clinical nutrition is estimated to grow from $59.6 billion in 2020 to $75.4 billion by 2025, at a compound annual growth rate (CAGR) of 4.8% during the forecast period of 2020-2025.
Report Includes
- 28 data tables and 55 additional tables
- An updated review of the global market for clinical nutrition within the industry
- Analyses of the global market trends, with data from 2018-2020, and projections of compound annual growth rates (CAGRs) through 2025
- Highlights of the key market regulations, new advances in clinical nutrition and nutritional sciences, and increasing demand for specific nutritional products; and their impact on the stakeholders in this market
- Estimation of current market size and potential growth forecast for clinical nutrition market, and corresponding market share analysis by nutrition type, end user, application area, and geography
- Analysis of market opportunities with a holistic study of Porter’s Analysis and PEST Analysis for relevant geographic regions in the clinical nutrition industry
- Competitive Landscape featuring major companies in the clinical nutrition market, their financial information, company share analysis and key development strategies
- Review of the U.S. patents issued for innovations in clinical nutrition products
- Profile description of the market leading players, including Abbott, B. Braun Melsungen AG, Baxter, Danone, DSM, Mead Johnson Nutrition Co. (MJN), Nestlé and Fresenius Kabi
Report Scope
Clinical nutrition is nutrition for patients in a healthcare setting. It is the practice of assessing whether a person is consuming an adequate amount of nutrients. This report analyzes market trends for clinical nutrition with data from 2018-2019, estimates from 2020, projections of compound annual growth rates (CAGR) through 2025 (forecast period 2020-2025) and regional markets for clinical nutrition.
The market has been segmented by type, application, end user and geography. By type, the market is segmented into enteral nutrition, parenteral nutrition and infant nutrition. The infant nutrition segment covers milk-based, organic, soy-based, prebiotics, probiotics and follow-up products. The enteral nutrition segment covers standard nutrition and disease-specific nutritional support. The parenteral nutrition segment in this report includes carbohydrates, lipids, trace elements, amino acids, vitamins and minerals. Products include, but are not limited to, the segments considered in this report. The applications of clinical nutrition considered in this report include therapeutic applications and healthcare settings. In therapeutic applications, the report covers oncology, gastroenterology, nephrology, neurology, diabetes, immunology, critical care and other diseases. The healthcare settings segment includes acute care hospitals, nursing homes, homecare settings and inpatient rehabilitation facilities. This report also includes a detailed background of medical nutrition therapy: oral nutrition supplements (dietary supplements, functional and fortified foods and food intolerance products) and clinical nutrition routes, enteral and parenteral. Market sizing was done for infant, enteral, parenteral, adult and elder nutrition. A regional market analysis for clinical nutrition is also covered in this report.
The research uncovers many paradigm shifts in the studied market, in terms of regional competitive advantage, competitive landscape among key players and market dynamics. A holistic study of the market has been carried out, incorporating various factors, from country-specific demographic conditions and business cycles to market specific microeconomic influences needed to analyze the future trends of this market. The report provides a comprehensive review of market drivers, restraints, opportunities and available patents. Key vendor analysis, new products, developments and financials are also provided, to enable easy decision making.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- The Global Market for Carotenoids (FOD025H)
- AI in Healthcare Regional Analysis Market: Middle East and North Africa (IFT314A)
- Polyester Resin: Global Markets (CHM156B)
- Global Markets and Technologies for Bioplastics (PLS050G)
- 2024 Manufacturing Research Review (MFG071D)
Report Highlights
The global clinical nutrition market should reach $60.8 billion by 2022 from $48.2 billion in 2017 at a compound annual growth rate (CAGR) of 4.8% for the period 2017-2022.
Related Reports
The Global Market for Carotenoids
The global market for carotenoids is estimated to increase from $2.1 billion in 2024 to reach $2.9 billion by 2029, at a compound annual growth rate (CAGR) of 6.7% from 2024 through 2029.
Intravenous (IV) Therapy and Vein Access: Global Markets
The global market for IV therapy and venous access devices is expected to grow from $57.0 billion in 2024 and is projected to reach $74.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2024 to 2029.
Probiotics in Food, Beverages, Dietary Supplements and Animal Feed
The global market for probiotics is expected to grow from $69.8 billion in 2024 and is projected to reach $102.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.9% during the forecast period of 2024 to 2029.
Nutraceuticals: Global Markets
The global market for nutraceuticals is expected to grow from $418.2 billion in 2024 and is projected to reach $571.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2024 to 2029.
Recent Reports
Epigenetics: Technologies and Global Markets
The global market for epigenetics research tools and reagents, IVDs and therapeutics is expected to grow from $4.8 billion in 2024 to $8.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.8% from 2024 through 2029.
High-Throughput Screening: Technologies and Global Markets
The global market for high-throughput screening (HTS) is expected to grow from $23.8 billion in 2024 to $39.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.5% from 2024 through 2029.
Neurology Market: A BCC Research Overview
The global market for neurology is estimated to increase from $67.3 billion in 2024 to reach $94.8 billion by 2029, at a compound annual growth rate (CAGR) of 7.1% from 2024 through 2029.
2023 Pharmaceuticals Research Review
This Pharmaceutical Research Review provides a sampling of the type of quantitative market information, analysis and guidance that has been aiding business decision making since the inception of BCC Research in 1971.
Alzheimer's Disease Therapeutics and Diagnostics: Global Markets
The global market for Alzheimer’s disease therapeutics and diagnostics was valued at $9 billion in 2023. This market is expected to grow from $9.7 billion in 2024 to $19.6 billion by 2029, at a compound annual growth rate (CAGR) of 15.1% from 2024 to 2029.
Top Trending Reports
Carbon Capture, Utilization & Storage Technologies
The global market for carbon capture, utilization and storage (CCUS) technologies is expected to grow from $3.4 billion in 2024 and is projected to reach $9.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.1% during the forecast period of 2024 to 2029.
Cell-Based Assays: Technologies and Global Markets
The global market for cell-based assays is estimated to increase from $35.3 billion in 2024 to reach $56.3 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Generative AI: Global Markets
The global market for generative AI was valued at $15.4 billion in 2023. It is projected to grow from $20.8 billion in 2024 to $94.4 billion by 2029, at a compound annual growth rate (CAGR) of 35.3% from 2024 through 2029.
Global Markets for Chemicals for Cosmetics & Toiletries
The global market for chemicals in cosmetics and toiletries is expected to grow from $27.7 billion in 2024 to $35.0 billion by 2029, at a compound annual growth rate (CAGR) of 4.8% from 2024 through 2029.
Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets
The global market for liquid biopsy is expected to grow from $4.6 billion in 2024 and is projected to reach $13.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.3% during the forecast period of 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More